244 related articles for article (PubMed ID: 24666309)
1. Design, synthesis, and antitumor screening of certain novel tetrahydroquinoline sulfonamides.
Alafeefy AM
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):189-94. PubMed ID: 24666309
[TBL] [Abstract][Full Text] [Related]
2. Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Ghorab MM; Noaman E
Eur J Med Chem; 2010 May; 45(5):1849-53. PubMed ID: 20149941
[TBL] [Abstract][Full Text] [Related]
3. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
6. Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Noaman E; Ghorab MM
Eur J Med Chem; 2010 Feb; 45(2):738-44. PubMed ID: 19944497
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pro-apoptotic effects of new sulfonamide derivatives via activating p38/ERK phosphorylation in cancer cells.
Cumaoglu A; Dayan S; Agkaya AO; Ozkul Z; Ozpozan NK
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):413-9. PubMed ID: 25198886
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of some novel tetrahydroquinolines as anticancer and antimicrobial agents.
Faidallah HM; Saqer AA; Alamry KA; Khan KA; Asiri AM
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):367-78. PubMed ID: 23607308
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
[TBL] [Abstract][Full Text] [Related]
12. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity evaluation of imidazole-based indeno[1,2-b]quinoline-9,11-dione derivatives.
Sarkarzadeh H; Miri R; Firuzi O; Amini M; Razzaghi-Asl N; Edraki N; Shafiee A
Arch Pharm Res; 2013 Apr; 36(4):436-47. PubMed ID: 23440577
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluations of the antiproliferative activity and aqueous solubility of novel carbazole sulfonamide derivatives as antitumor agents.
Sun L; Wang C; Hu X; Wu Y; Jiang Z; Li Z; Chen X; Hu L
Bioorg Chem; 2020 Jun; 99():103766. PubMed ID: 32247110
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
Ghorab MM; Ragab FA; Hamed MM
Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity.
Szalóki G; Pantzou A; Prousis KC; Mavrofrydi O; Papazafiri P; Calogeropoulou T
Bioorg Med Chem; 2014 Dec; 22(24):6980-8. PubMed ID: 25456391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]